Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study)
Clinical trial NCT01202721 · TERMINATED
Trial details
- NCT number
- NCT01202721
- Sponsor
- Hamilton Health Sciences Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2016-04-19
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.